Boost in the Number of Radiology and Medical Imaging Startups Leading to the Growth of Global Artificial Intelligence (AI) Enabled Medical Imaging Market

The rising adoption of AI in hospitals, diagnostic labs, boost in the number of radiology and medical imaging startups, and burgeoning investment by the healthcare industry in AI enabled medical imaging are some of the factors leading to a positive impact toward the growth of Global artificial intelligence (AI) enabled medical imaging market. Besides these, rising numbers of diagnostics, growing use of imaging biomarkers in clinical practices, and increasing incidences of cancer cases are some of the factors proliferating the growth of the market in the forthcoming timeline.

Moreover, the COVID-19 pandemic has had a positive impact on the market. Various organizations are turning toward medical imaging and imaging analytics tools in order to improve the virus detection, treatment, and prevention.

View Report: https://www.marknteladvisors.com/research-library/global-artificial-intelligence-enabled-medical-imaging-market.html?utm_source=openpr&utm_medium=Pr

According to MarkNtel Advisors’ research report titled “Global Artificial Intelligence (AI) Enabled Medical Imaging Market Analysis, 2021”, the Global Artificial Intelligence (AI) Enabled Medical Imaging market is anticipated to grow at a CAGR of around 29% during 2021-26. Based on Deployment, Cloud segment is anticipated to grow at a highest CAGR by 2025 in the Global AI enabled medical imaging market. The cloud technology helps in the processing of medical images for remote visualization. It also helps the doctors to access to patient records and history and improves administration, billing, and clinical treatment as the data is stored on the cloud. Thus, the surging inclination toward cloud deployment is projected to drive the growth of the segment in the coming years.

“Global Artificial Intelligence (AI) Enabled Medical Imaging Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and growth opportunities available for Artificial Intelligence (AI) Enabled Medical Imaging providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.

Asia-Pacific Exhibits the Fastest Growth
Asia-Pacific is projected to attain highest CAGR by 2025. The growth of the market is attributed to rising incidences of breast cancer and prostate cancer, escalating government investment toward the healthcare development, and burgeoning adoption of AI in healthcare. Moreover, rising spending toward medical imaging startups, boost in geriatric population, and strong foothold of technology-based companies are anticipated to accentuate the growth of Artificial Intelligence (AI) Enabled Medical Imaging market in this region as stated in MarkNtel Advisors’ research report “Global Artificial Intelligence (AI) Enabled Medical Imaging Market Analysis, 2021”.

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @ https://www.marknteladvisors.com/query/request-sample/global-artificial-intelligence-enabled-medical-imaging-market.html

According to MarkNtel Advisors, the key players with a considerable market share in the Global Artificial Intelligence (AI) Enabled Medical Imaging market are Aidoc, Arterys Inc., Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, ContextVision AB, EnvoyAI, Fujifilm Holdings Corporation, General Electric Company, iCAD, Inc., Koninklijke Philips N.V., Mirada Medical Limited, NVIDIA Corporation, Nuance Communications, Inc., Resonance Health Ltd., Samsung Electronics Co., Ltd. etc.,

Market Segmentation:
1. By Components (Hardware, Software [Perpetual Software License, Subscription Software License, Pay as You Go Software License])
2. By Workflow (Image Analysis, Image Acquisition, Detection, Reporting & Communication, Diagnosis & Treatment Decision Support, Predictive Analysis & Risk Assessment, Equipment Maintenance, Triage)
3. By Therapeutic Application (Specialty Imaging [Cardiology, Oncology {Lung Cancer, Breast Cancer, Other Cancers}, Neurology, Respiratory, Orthopedics, Others], General Imaging)
4. By Deployment (Cloud, On-Premise)
5. By Modality (Computed Tomography, Magnetic Resonance, Ultrasound, X-Ray, Mammography, Multimodality Imaging Systems, Others)
6. By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa)
7. By Country (US, Canada, Mexico, Brazil, UK, Germany, France, Italy, Sweden, Switzerland, Russia, The Netherlands, China, Japan, South Korea, India, Australia, Singapore, GCC),
8. By Company (Aidoc, Arterys Inc., Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, ContextVision AB, EnvoyAI, Fujifilm Holdings Corporation, General Electric Company, iCAD, Inc., Koninklijke Philips N.V., Mirada Medical Limited, NVIDIA Corporation, Nuance Communications, Inc., Resonance Health Ltd., Samsung Electronics Co., Ltd. etc.)

Key questions answered in the study:
1. What are the current and future trends of the Artificial Intelligence (AI) Enabled Medical Imaging industry?
2. How the industry has been evolving in terms of end-user demand and application areas?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Artificial Intelligence (AI) Enabled Medical Imaging industry?
5. What is the customer orientation, purchase behavior, and expectations from the Artificial Intelligence (AI) Enabled Medical Imaging firms across various regions?

MarkNtel Advisors
1147 88AVE, Delta, British Columbia, BC,V4C,3B8, CANADA
Email: updates@markntelgroup.com
Tel: +1613-707-5086
Website: https://www.marknteladvisors.com/?utm_source=Openpr&utm_medium=pr

MarkNtel Advisors is a leading research, consulting and data analytics firm that provides a wide range of strategic reports on diverse industry verticals to a substantial and varied client base that includes multinational corporations, financial institutions, governments, and individuals.

We specialize in niche industries and emerging geographies to support our clients in the formulation of strategies viz. Go to Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, trend analysis, etc. in around 15 industry verticals to enable our clients in identifying attractive investment opportunities and maximizing ROI through an early mover advantage.

This release was published on openPR.